Investing Profile

Andrew Levin

VC
Photo of Andrew Levin, Managing Partner at RA Capital
Your Intro Paths to Andrew Levin
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Andrew Levin on

cb
Current Investing Position
RA Capital Managing Partner
Investments On Record
18

Andrew Levin is on these Sector & Stage Rankings

Andrew Levin's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
Aktis Oncology
Series BSep 2024$180M
$330M
Co-investors: Jason Ruth (5am Ventures), Todd Foley (MPM Capital)
Superluminal Medicines
Series ASep 2024$120M
SeedAug 2023$33M
$150M
Co-investors: Dylan Morris (Insight Partners)
Navigator Medicines
Series AAug 2024$100M
$100M
Co-investors: Wouter Joustra (Forbion)
Eliem Therapeutics
Post Ipo EquityApr 2024$120M
Series BMay 2021$60M
Series AMar 2021$80M
$260M
Co-investors: Liam Ratcliffe (Access Biotechnology), Ohad Hammer (Pontifax Venture Capital)
Lusaris Therapeutics
Series ANov 2022$60M
$60M
Metagenomi
Series BJan 2022$180M
Series ANov 2020$75M
$280M
Co-investors: Sebastian Bernales (Humboldt Fund), Victor Wang (HOF Capital), Kyle Kurpinski (Tencent Holdings), Jeremy Yap
Expansion Therapeutics
Series BSep 2021$80M
Series AJan 2018$55M
$140M
Co-investors: Scott Rocklage (5am Ventures), Beth Seidenberg (Westlake Village BioPartners)
Delix Therapeutics
Series ASep 2021$70M
$70M
Co-investors: Ken Belotsky (Negev Capital), Vasudev Bailey (Artis Ventures (AV)), Matias Serebrinsky (PsyMed Ventures)